Puma Biotechnology (PBYI) Return on Equity [ROE] (2012 - 2026)
Puma Biotechnology's Return on Equity [ROE] came in at 23.35% for Q2 2026, down 18.26 percentage points from 41.61% a year earlier but up 0.87 percentage points from the prior quarter.
Powered by 
Analysis
Puma Biotechnology (PBYI) Return on Equity [ROE] (2012 - 2026) Analysis & Trends
For FY2025, Puma Biotechnology's Return on Equity [ROE] was 32.17%, down 0.94 percentage points from FY2024.
- Return on Equity [ROE] carries a five-year change of +1074.47 percentage points (FY2020 to FY2025).
- Going back by year, Return on Equity [ROE] was 33.11% in FY2024 (-24.43 pp), 57.54% in FY2023 (+57.52 pp) and 0.02% in FY2022.
- The five-year range for quarterly Return on Equity [ROE] is -2083.72% (Q1 2022) to 46.94% (Q3 2022).
- Year-over-year, Return on Equity [ROE] increased in four of the last eight quarters, with an average year-over-year change of -0.19 percentage points.
- The fastest year-over-year change in Return on Equity [ROE] over five years came in Q1 2023 (a gain of 2103.97 percentage points), and the weakest in Q1 2022 (a drop of 1572.76 percentage points).
- Business Quant data shows PBYI's Return on Equity [ROE] at 22.48% (Q1 2026), 29.14% (Q4 2025) and 28.10% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | Puma Biotechnology | 420.82 Mn | 19.27 Mn | 39.86 Mn | 20.42% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 20.42% |
| Jun 30, 2026 | 24.25% |
| Mar 31, 2026 | 23.61% |
| Dec 31, 2025 | 30.30% |
| Sep 30, 2025 | 30.64% |
| Jun 30, 2025 | 43.97% |
| Mar 31, 2025 | 35.27% |
| Dec 31, 2024 | 30.63% |
| Sep 30, 2024 | 38.87% |
| Jun 30, 2024 | 17.53% |
| Mar 31, 2024 | 29.45% |
| Dec 31, 2023 | 46.84% |
| Sep 30, 2023 | 10.75% |
| Jun 30, 2023 | -8.67% |
| Mar 31, 2023 | 20.25% |
| Dec 31, 2022 | 0.01% |
| Sep 30, 2022 | 46.94% |
| Jun 30, 2022 | -256.52% |
| Mar 31, 2022 | -2,083.72% |
| Sep 30, 2021 | -520.24% |
API Access
Puma Biotechnology Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=PBYI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "PBYI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=PBYI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();